CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 19 No. 11
Practice & Policy 

Oncologists seek refuge from stalled economy by joining forces

BY JOHN SCHIESZER | December 5, 2010

More oncologists in the past few years have opted to consolidate with other practices in their area or sought employment at hospitals. Results from an ongoing survey highlights the ups and down of cancer care, with most professionals reporting they are happy with their chosen specialty.

Despite significant changes in the oncology landscape—the closure of independent cancer care centers, cuts to Medicare reimbursement rates, the battle over healthcare reform—oncologists say they are happy with their careers and would choose their specialty again, according to a new survey. But even the most satisfied oncologist has made concessions and changes in order to keep up with the times, based on the results of another survey.

Epocrates Market Research interviewed 200 U.S. oncologists in late 2009 on a range of issues related to practicing medicine and the healthcare industry. Epocrates is a developer of mobile clinical reference software. The Association of Community Cancer Centers (ACCC) cosponsored the "Cancer Care Trends in Community Cancer Centers Survey" project with Eli Lilly. This is year two of a three-year survey first conducted in 2008. The 2009 survey included ACCC members at 84 hospitals in the U.S. (Oncology Issues, July/August, 2010).

The Epocrates survey showed that 84% of oncologists would choose a career in their specialty again, 78% would recommend their specialty to medical students, and 56% find it helpful when patients bring in information they’ve found on the Internet.

However, oncologists were divided on how healthcare reform will affect oncology. Approximately 40% of the respondents thought there would be "a significant positive impact" for patients seeking cancer treatment under healthcare reform. The survey showed that approximately 30% of respondents thought the overall practice of oncology would experience "a somewhat positive impact" from healthcare reform.

David Graham, MD, a spokesperson for Epocrates, pointed out that, under healthcare reform, more money has been promised for oncology-related research. Ironically, the survey showed that oncologists don’t expect that to be the case: The 30% who predicted a positive impact dropped to 20% when the question was about healthcare reform and research. "I was surprised by the findings on oncology-related research [because] it seems like there will be more spent on this…federal payers are going to be more supportive of clinical trials research," said Dr. Graham, who is also medical director of clinical trials at Carle Physicians Group in Urbana, Ill.

The survey also asked physicians about their use of information technology. More than 50% of oncologists agreed that mobile clinical reference software, electronic medical record (EMR) systems, electronic prescribing, bedside bar code scanning of all medications, and computer physician order entry were helpful tools for avoiding errors.

"The amount of time you [save] using electronic references is a pretty interesting bit of information," Dr. Graham said. "I think all physicians are going to rely on online tools like this. They aren’t going to have a choice in the matter."

Results from the ACCC survey also demonstrated a jump in the use of EMRs in 2010. In 2009, 84% of respondents reported utilization of EMRs vs 65% in 2008. More than half (54%) of respondents who use EMRs reported using more than one software program.

But an EMR system may have been the only big investment that oncologists were willing to make this year. The survey also showed that cancer programs delayed construction projects and some equipment purchases, such as PET or PET/CT scanners. On the other hand, more programs offered digital mammography, image-guided radiotherapy, and prostate brachytherapy in 2010 than offered them in 2009.

Personnel was another area where practices cut back. Among the ACCC survey respondents, 57% reported putting a freeze on hiring while 29% had reduced staff and 10% had reduced services.

The most dramatic change was the number of respondents who reported either consolidating with other practices in their area or seeking employment at area hospitals. Almost half the respondents said they expect consolidation of physician oncology practices in their area, up from 30% in the 2009 survey.

"There is a sense that oncologists are starting to abandon their practices and are joining with hospitals as hospital-based physicians," said Al Benson III, MD, ACCC president and a professor of medicine at Northwestern University in Chicago.

"I think the biggest finding that really jumped out at us was that the recession is not affecting the hospitals as much as oncologists. They did not get impacted like the community oncologists," said Lee Blansett, senior vice president of Oncology Market Access for Kantar Health, based in Foster City, Calif. "This is a big trend change here. There was nothing subtle about it."

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Gregory Pawelski | December 06, 2010 2:24 PM EST

There is some innate goodness of people who go into oncology. At the time when most oncologists practicing today made the decision to become oncologists, there was no chemotherapy concession. Most of them probably had a personal life experience which created the calling to do battle against the great crab. At the time people make their most important decisions in life, people are at the most idealistic period of their lives.

In their environnment, it is mandatory from a purely human standpoint, to take refuge in the smallest of successes. The shrinkage of a tumor lasting four weeks. The temporary relief of pain. Just like a trauma victim will love forever the surgeon who fixed his/her compound fracture, the cancer patient feels genuine, heartfelt gratitude to the oncologist during periods when the cancer crab retreats.

But the oncologist knows it is just the eye in the hurricane. The eye passes all to quickly, and then the patient is beaten by the back half of the storm, which is more deadly than the front. So the oncologist only rarely gets to share in the celebration of remissions. He/she's already worried about the day to come, when the really bad news needs to be delivered to the patient and the remission is instantly forgotten.

But even bettersweet victories are better than no victories at all. So oncoloigsts will still give more chemotherapy than otherwise warranted, even without the financial incentives. I would imagine some are influenced by the whole state of affairs, possibly without even entirely admitting it. There are so many ways for humans to rationalize their behavior.

The solution is to change the system. Take physicians out of the retail pharmaceutical business and let them be doctors again.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Soluble HER2 Levels Prognostic Factor in HER2+ Breast Cancer
  • ASCO: PD-L1 Antibody Elicits Durable Response in RCC
  • RECORD-3: Sunitinib Still Standard First-Line Treatment in Metastatic RCC
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy